Other malignancies in the history of CLL: an international multicenter study conducted by ERIC, the European Research Initiative on CLL, in HARMONYThomas Chatzikonstantinou, Elżbieta Kalicińska, Lukáš Smolej et al.|EClinicalMedicine|2023Cited by 21
Therapeutic strategies and treatment sequencing in patients with chronic lymphocytic leukemia: An international study of ERIC, the European Research Initiative on CLLThomas Chatzikonstantinou, Thomas Longval, Lydia Scarfò et al.|HemaSphere|2024Cited by 2
Lenalidomide Consolidation Improves Measurable Residual Disease (MRD) Rates and Progression Free Survival in Patients with Chronic Lymphocytic Leukemia Following Initial FCR Chemotherapy - Final Analysis of CLL6 Residuum Study of the Australian Leukaemia and Lymphoma Group (ALLG) and the French Innovative Leukemia Organization (FILO)Thérèse Aurran‐Schleinitz, David Gottlieb, Stephen P. Mulligan et al.|Blood|2023Cited by 1
S149: OTHER MALIGNANCIES IN THE HISTORY OF CLL: THE FINAL ANALYSIS OF THE INTERNATIONAL MULTICENTER STUDY CONDUCTED BY ERIC, IN HARMONY.Thomas Chatzikonstantinou, Arnon P. Kater, Lydia Scarfò et al.|HemaSphere|2023Cited by 0